COST EFFECTIVENESS OF OVERACTIVE BLADDER TREATMENT WITH MIRABEGRON IN PATIENTS IN SOUTH KOREA

被引：0
|
作者：
Suh, D. [1 ]
Lee, S. [1 ]
Lim, S. J. [1 ]
Song, J. [1 ]
Ko, G. [2 ]
机构：
[1] Chung Ang Univ, Seoul, South Korea
[2] Astellas Pharma Inc, Seoul, South Korea
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.08.502
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK8
引用
收藏
页码：A847 / A847
页数：1
相关论文
共 50 条
  • [1] The cost effectiveness of mirabegron for the treatment of overactive bladder: three US perspectives
    Wielage, R. C.
    Perk, S.
    Campbell, N. L.
    Ng, D.
    Klein, T. M.
    Posta, L. M.
    Yuran, T.
    Klein, R. W.
    Perkins, A.
    Berner, T.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S67 - S67
  • [2] COST-EFFECTIVENESS OF MIRABEGRON COMPARED WITH ANTIMUSCARINICS FOR THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER IN THE UNITED KINGDOM
    Maman, K.
    Neine, M.
    Briquet, B.
    Nazir, J.
    Odeyemi, I. A. O.
    Hakimi, Z.
    Garnham, A.
    Aballea, S.
    VALUE IN HEALTH, 2013, 16 (07) : A633 - A634
  • [3] COST-EFFECTIVENESS OF MIRABEGRON VERSUS ANTIMUSCARINICS FOR THE TREATMENT OF OVERACTIVE BLADDER IN ARGENTINA
    Ramos, B.
    Sanchez Trujillo, L. A.
    Walker, D.
    Anaya, P.
    VALUE IN HEALTH, 2020, 23 : S378 - S378
  • [4] Cost Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in Colombia
    Parise, Helene
    Espinosa, Robert
    Dea, Katherine
    Anaya, Pablo
    Montoya, Giovanny
    Bin Ng, Daniel
    PHARMACOECONOMICS-OPEN, 2020, 4 (01) : 79 - 90
  • [5] Cost Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in Colombia
    Hélène Parise
    Robert Espinosa
    Katherine Dea
    Pablo Anaya
    Giovanny Montoya
    Daniel Bin Ng
    PharmacoEconomics - Open, 2020, 4 : 79 - 90
  • [6] MIRABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER
    Gras, J.
    DRUGS OF TODAY, 2012, 48 (01) : 25 - 32
  • [7] Mirabegron in the treatment of overactive bladder
    Maggiore, Umberto Leone Roberti
    Cardozo, Linda
    Ferrero, Simone
    Sileo, Filomena
    Cola, Alice
    Torella, Marco
    Colacurci, Nicola
    Candiani, Massimo
    Salvatore, Stefano
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (06) : 873 - 887
  • [8] Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH)
    Seung-June Oh
    Sung Tae Cho
    Hann-Chorng Kuo
    Eric Chieh-Lung Chou
    Yu-Chao Hsu
    Kyu-Sung Lee
    Farid Hadi
    Yi Song
    Budiwan Sumarsono
    Advances in Therapy, 2024, 41 : 1652 - 1671
  • [9] COST-EFFECTIVENESS ANALYSIS OF MIRABEGRON VERSUS TOLTERODINE EXTENDED RELEASE IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER IN THE UNITED STATES
    Xie, J.
    Zhou, Z. Y.
    Bui, C. N.
    Yan, Y.
    De, G.
    Runken, M. C.
    Wu, E. Q.
    VALUE IN HEALTH, 2012, 15 (07) : A457 - A457
  • [10] Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH)
    Oh, Seung-June
    Cho, Sung Tae
    Kuo, Hann-Chorng
    Chou, Eric Chieh-Lung
    Hsu, Yu-Chao
    Lee, Kyu-Sung
    Hadi, Farid
    Song, Yi
    Sumarsono, Budiwan
    ADVANCES IN THERAPY, 2024, 41 (04) : 1652 - 1671
12345